Editas Medicine, Inc. (EDIT) Q1 2024 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Editas Medicine, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.029 -- 00:00:05.674 Good morning and welcome to the Editas Medicine first quarter 2024 conference call. 00:00:05.674 -- 00:00:08.756 All participants are now in a listen-only mode. 00:00:08.756 -- 00:00:12.379 There will be a question and answer session at the end of this call. 00:00:12.379 -- 00:00:16.663 Please be advised that this call is being recorded at the company's request. 00:00:16.663 -- 00:00:21.147 I would now like to turn the call over to Christy Barnett, Corporate Communications and 00:00:21.147 -- 00:00:24.748 Investor Relations at Editas Medicine. 00:00:26.872 -- 00:00:31.722 Thank you. Good morning, everyone, and welcome to our first quarter 2024 00:00:31.722 -- 00:00:36.604 conference call. Earlier this morning, we issued a press release providing our financial 00:00:36.604 -- 00:00:41.646 results and recent corporate updates. A replay of today's call will be available in the 00:00:41.646 -- 00:00:47.168 investors section of our website approximately two hours after its completion. 00:00:47.168 -- 00:00:51.409 After our prepared remarks, we will open the call for Q&A. 00:00:51.409 -- 00:00:56.030 As a reminder, various remarks that we make during this call about the company's future 00:00:56.030 -- 00:01:01.418 expectations, plans, and prospects constitute forward-looking statements 00:01:01.418 -- 00:01:05.700 for the purposes of the safe harbor provisions under the Private Securities Litigation 00:01:05.700 -- 00:01:08.341 Reform Act of 1995. 00:01:08.341 -- 00:01:13.183 Actual results may differ materially from those indicated by these forward-looking statements 00:01:13.183 -- 00:01:18.445 as a result of various important factors, including those discussed in the risk factors 00:01:18.445 -- 00:01:23.488 section of our most recen...